SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/05/20 Ametek Inc 10-Q 3/31/20 84:6.8M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 675K 2: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 196K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 30K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 30K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 24K 6: EX-32.2 Certification -- §906 - SOA'02 HTML 24K 55: R1 Cover Page HTML 78K 21: R2 Consolidated Statement of Income HTML 75K 35: R3 Consolidated Statement of Comprehensive Income HTML 27K 76: R4 Consolidated Balance Sheet HTML 109K 56: R5 Consolidated Statement of Stockholders' Equity HTML 77K 22: R6 Consolidated Statement of Stockholders' Equity HTML 34K (Parenthetical) 36: R7 Condensed Consolidated Statement of Cash Flows HTML 98K 78: R8 Basis of Presentation HTML 31K 53: R9 Recent Accounting Pronouncements HTML 36K 60: R10 Revenues HTML 210K 82: R11 Earnings Per Share HTML 42K 38: R12 Fair Value Measurements HTML 54K 27: R13 Hedging Activities HTML 30K 61: R14 Inventories, net HTML 41K 83: R15 Leases HTML 91K 39: R16 Acquisition and Divestiture HTML 44K 28: R17 Goodwill HTML 48K 59: R18 Income Taxes HTML 36K 84: R19 Share-Based Compensation HTML 117K 43: R20 Retirement and Pension Plans HTML 60K 13: R21 Contingencies HTML 40K 62: R22 Realignment Costs HTML 38K 69: R23 Significant Accounting Policies (Policies) HTML 29K 44: R24 Revenues (Tables) HTML 212K 14: R25 Earnings Per Share (Tables) HTML 41K 63: R26 Fair Value Measurements (Tables) HTML 49K 70: R27 Inventories, net (Tables) HTML 42K 46: R28 Leases (Tables) HTML 88K 12: R29 Acquisition and Divestiture (Tables) HTML 37K 30: R30 Goodwill (Tables) HTML 48K 42: R31 Income Taxes (Tables) HTML 34K 81: R32 Share-Based Compensation (Tables) HTML 116K 58: R33 Retirement and Pension Plans (Tables) HTML 57K 29: R34 Realignment Costs (Tables) HTML 37K 41: R35 Recent Accounting Pronouncements - Additional HTML 28K Information (Detail) 80: R36 Revenues - Outstanding Contract Asset and HTML 37K (Liability) Accounts (Detail) 57: R37 Revenues - Additional Information (Detail) HTML 42K 31: R38 Revenues - Information about Operations in HTML 63K Different Geographic Areas (Detail) 40: R39 Revenues - Information about Operations in HTML 29K Different Geographic Areas (Parenthetical) (Detail) 16: R40 Revenues - Major Products and Services in HTML 42K Reportable Segments (Detail) 49: R41 Revenues - Timing of Revenue Recognition (Detail) HTML 40K 74: R42 Revenues - Changes in Accrued Product Warranty HTML 32K Obligation (Detail) 68: R43 Earnings Per Share - Number of Weighted Average HTML 33K Shares (Detail) 15: R44 Fair Value Measurements - Fair Value of Assets HTML 28K Measured on Recurring Basis (Detail) 48: R45 Fair Value Measurements - Additional Information HTML 40K (Detail) 73: R46 Fair Value Measurements - Fair Value Disclosures HTML 30K of Financial Instrument Liabilities (Detail) 67: R47 Hedging Activities - Additional Information HTML 38K (Detail) 17: R48 Inventories, net - Inventories (Detail) HTML 36K 47: R49 Leases- Components of Lease Expense (Detail) HTML 31K 33: R50 Leases - Supplemental Balance Sheet Information HTML 32K Related to Leases (Detail) 24: R51 Leases - Supplemental Cash Flow Information HTML 31K Related to Leases (Detail) 52: R52 Leases - Maturities of lease liabilities (Detail) HTML 44K 77: R53 Acquisition and Divestiture - Additional HTML 58K Information (Detail) 34: R54 Acquisition and Divestiture - Allocation of HTML 43K Aggregate Purchase Price of Acquired Net Assets (Detail) 25: R55 Acquisition and Divestiture - Allocation of HTML 28K Aggregate Purchase Price of Acquired Net Assets (Parenthetical) (Detail) 54: R56 Goodwill - Changes in Carrying Amounts of Goodwill HTML 41K by Segment (Detail) 79: R57 Income Taxes - Additional Information (Detail) HTML 33K 37: R58 Income Taxes - Reconciliation of Liability for HTML 31K Uncertain Tax Positions (Detail) 23: R59 Share-Based Compensation - Additional Information HTML 85K (Detail) 65: R60 Share-Based Compensation - Total Share-Based HTML 33K Compensation Expense (Detail) 71: R61 Share-Based Compensation - Weighted Average HTML 38K Assumptions Used for Estimating Fair Values of Stock Options Granted (Detail) 50: R62 Share-Based Compensation - Summary of Stock Option HTML 61K Activity and Related Information (Detail) 18: R63 Share-Based Compensation - Summary of Nonvested HTML 49K Restricted Stock Activity and Related Information (Detail) 66: R64 Retirement and Pension Plans - Additional HTML 28K Information (Detail) 72: R65 Retirement and Pension Plans - Components of Net HTML 48K Periodic Pension Benefit Expense (Income) (Detail) 51: R66 Contingencies - Additional Information (Detail) HTML 43K 19: R67 Realignment Costs - Schedule of Accrued HTML 37K Liabilities in Company's Consolidated Balance Sheet Included Amounts Related to Realignment Costs (Detail) 64: R68 Realignment Costs - Additional Information HTML 43K (Detail) 45: XML IDEA XML File -- Filing Summary XML 149K 26: XML XBRL Instance -- d923322d10q_htm XML 1.62M 20: EXCEL IDEA Workbook of Financial Reports XLSX 68K 8: EX-101.CAL XBRL Calculations -- ame-20200331_cal XML 133K 9: EX-101.DEF XBRL Definitions -- ame-20200331_def XML 456K 10: EX-101.LAB XBRL Labels -- ame-20200331_lab XML 993K 11: EX-101.PRE XBRL Presentations -- ame-20200331_pre XML 766K 7: EX-101.SCH XBRL Schema -- ame-20200331 XSD 136K 32: JSON XBRL Instance as JSON Data -- MetaLinks 327± 477K 75: ZIP XBRL Zipped Folder -- 0001193125-20-133597-xbrl Zip 174K
10-Q |
i ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
i ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
i Delaware |
i 14-1682544 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
i 1100 Cassatt Road i Berwyn, i Pennsylvania
|
i 19312-1177 | |
(Address of principal executive offices) |
(Zip Code) |
i Large accelerated filer |
☒ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☐ (Do not check if a smaller reporting company) |
Smaller reporting company |
i ☐ | |||
Emerging growth company |
i ☐ |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
i Common Stock |
i AME |
i New York Stock Exchange |
Three Months Ended |
||||||||
2019 |
||||||||
Net sales |
$ |
i 1,202,218 |
$ | i 1,287,691 |
||||
Cost of sales |
i 824,647 |
i 851,307 |
||||||
Selling, general and administrative |
i 145,531 |
i 153,125 |
||||||
Total operating expenses |
i 970,178 |
i 1,004,432 |
||||||
Operating income |
i 232,040 |
i 283,259 |
||||||
Interest expense |
( i 22,741 |
) |
( i 22,653 |
) | ||||
Other income (expense), net |
i 141,776 |
( i 3,668 |
) | |||||
Income before income taxes |
i 351,075 |
i 256,938 |
||||||
Provision for income taxes |
i 70,459 |
i 52,670 |
||||||
Net income |
$ |
i 280,616 |
$ | i 204,268 |
||||
Basic earnings per share |
$ |
i 1.23 |
$ | i 0.90 |
||||
Diluted earnings per share |
$ |
i 1.22 |
$ | i 0.89 |
||||
Weighted average common shares outstanding: |
||||||||
Basic shares |
i 228,962 |
i 226,861 |
||||||
Diluted shares |
i 230,872 |
i 228,686 |
||||||
Dividends declared and paid per share |
$ |
i 0.18 |
$ | i 0.14 |
||||
Three Months Ended |
||||||||
2019 |
||||||||
Total comprehensive income |
$ |
i 238,017 |
$ | i 215,281 |
||||
March 31, |
||||||||
2019 |
||||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
i 1,253,382 |
$ | i 393,030 |
||||
Receivables, net |
i 712,195 |
i 744,760 |
||||||
Inventories, net |
i 654,298 |
i 624,567 |
||||||
Other current assets |
i 154,616 |
i 263,414 |
||||||
Total current assets |
i 2,774,491 |
i 2,025,771 |
||||||
Property, plant and equipment, net |
i 534,786 |
i 548,908 |
||||||
Right of use assets, net |
i 168,543 |
i 179,679 |
||||||
Goodwill |
i 4,075,633 |
i 4,047,539 |
||||||
Other intangibles, net |
i 2,768,204 |
i 2,762,872 |
||||||
Investments and other assets |
i 280,289 |
i 279,790 |
||||||
Total assets |
$ |
i 10,601,946 |
$ | i 9,844,559 |
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Short-term borrowings and current portion of long-term debt, net |
$ |
i 510,792 |
$ | i 497,449 |
||||
Accounts payable |
i 373,900 |
i 377,219 |
||||||
Customer advanced payments |
i 174,890 |
i 156,818 |
||||||
Income taxes payable |
i 76,630 |
i 30,292 |
||||||
Accrued liabilities and other |
i 341,459 |
i 364,080 |
||||||
Total current liabilities |
i 1,477,671 |
i 1,425,858 |
||||||
Long-term debt, net |
i 2,741,798 |
i 2,271,292 |
||||||
Deferred income taxes |
i 553,658 |
i 536,140 |
||||||
Other long-term liabilities |
i 502,816 |
i 495,777 |
||||||
Total liabilities |
i 5,275,943 |
i 4,729,067 |
||||||
Stockholders’ equity: |
||||||||
Common stock |
i 2,664 |
i 2,662 |
||||||
Capital in excess of par value |
i 837,755 |
i 832,821 |
||||||
Retained earnings |
i 6,626,703 |
i 6,387,612 |
||||||
Accumulated other comprehensive loss |
( i 575,738 |
) |
( i 533,139 |
) | ||||
Treasury stock |
( i 1,565,381 |
) |
( i 1,574,464 |
) | ||||
Total stockholders’ equity |
i 5,326,003 |
i 5,115,492 |
||||||
Total liabilities and stockholders’ equity |
$ |
i 10,601,946 |
$ | i 9,844,559 |
||||
Three months ended |
||||||||
2019 |
||||||||
Capital stock |
||||||||
Preferred stock, $ i i 0.01 /
par value |
$ | — |
$ | — |
||||
Common stock, $ i i 0.01 /
par value |
||||||||
Balance at the beginning of the period |
i 2,662 |
i 2,640 |
||||||
Shares issued |
i 2 |
i 7 |
||||||
Balance at the end of the period |
i 2,664 |
i 2,647 |
||||||
Capital in excess of par value |
||||||||
Balance at the beginning of the period |
i 832,821 |
i 706,743 |
||||||
Issuance of common stock under employee stock plans |
( i 2,914 |
) |
i 24,309 |
|||||
Share-based compensation costs |
i 7,848 |
i 7,121 |
||||||
Balance at the end of the period |
i 837,755 |
i 738,173 |
||||||
Retained earnings |
||||||||
Balance at the beginning of the period |
i 6,387,612 |
i 5,653,811 |
||||||
Net income |
i 280,616 |
i 204,268 |
||||||
Cash dividends paid |
( i 41,165 |
) |
( i 31,766 |
) | ||||
Adoption of ASU 2016-13 |
( i 360 |
) |
— |
|||||
Balance at the end of the period |
i 6,626,703 |
i 5,826,313 |
||||||
Accumulated other comprehensive (loss) income |
||||||||
Foreign currency translation: |
||||||||
Balance at the beginning of the period |
( i 286,248 |
) | ( i 302,138 |
) | ||||
Translation adjustments |
( i 67,089 |
) |
i 8,964 |
|||||
Change in long-term intercompany notes |
( i 5,501 |
) |
( i 4,416 |
) | ||||
Net investment hedge instruments gain (loss), net of tax of ( $ i 9,117) and ($ i 1,130)
for the period ended March 31, 2020 and 2019, respectively |
i 28,308 |
i 3,508 |
||||||
Balance at the end of the period |
( i 330,530 |
) |
( i 294,082 |
) | ||||
Defined benefit pension plans: |
||||||||
Balance at the beginning of the period |
( i 246,891 |
) | ( i 248,950 |
) | ||||
Amortization of net actuarial loss (gain) and other, net of tax of ($ i 531) and ($ i 873)
for the period ended March 31, 2020 and 2019, respectively |
i 1,683 |
i 2,957 |
||||||
Balance at the end of the period |
( i 245,208 |
) |
( i 245,993 |
) | ||||
Accumulated other comprehensive loss at the end of the period |
( i 575,738 |
) |
( i 540,075 |
) | ||||
Treasury stock |
||||||||
Balance at the beginning of the period |
( i 1,574,464 |
) | ( i 1,570,184 |
) | ||||
Issuance of common stock under employee stock plans |
i 9,184 |
( i 116 |
) | |||||
Purchase of treasury stock |
( i 101 |
) |
( i 137 |
) | ||||
Balance at the end of the period |
( i 1,565,381 |
) |
( i 1,570,437 |
) | ||||
Total stockholders’ equity |
$ |
i 5,326,003 |
$ | i 4,456,621 |
||||
Three Months Ended |
||||||||
2019 |
||||||||
Cash provided by (used for): |
||||||||
Operating activities: |
||||||||
Net income |
$ |
i 280,616 |
$ | i 204,268 |
||||
Adjustments to reconcile net income to total operating activities: |
||||||||
Depreciation and amortization |
i 66,067 |
i 57,500 |
||||||
Deferred income taxes |
( i 4,042 |
) |
i 12,739 |
|||||
Share-based compensation expense |
i 7,848 |
i 7,121 |
||||||
Gain on sale of business |
( i 141,020 |
) |
— |
|||||
Gain on sale of facilities |
( i 4,592 |
) |
( i 735 |
) | ||||
Net change in assets and liabilities, net of acquisitions |
i 71,199 |
( i 84,167 |
) | |||||
Pension contributions |
( i 1,505 |
) |
( i 715 |
) | ||||
Other, net |
( i 3,819 |
) |
i 246 |
|||||
Total operating activities |
i 270,752 |
i 196,257 |
||||||
Investing activities: |
||||||||
Additions to property, plant and equipment |
( i 16,931 |
) |
( i 21,417 |
) | ||||
Purchases of businesses, net of cash acquired |
( i 116,605 |
) |
— |
|||||
Proceeds from sale of business |
i 245,311 |
— |
||||||
Proceeds from sale of facilities |
i 5,463 |
i 765 |
||||||
Other, net |
( i 1,681 |
) |
i 2,902 |
|||||
Total investing activities |
i 115,557 |
( i 17,750 |
) | |||||
Financing activities: |
||||||||
Net change in short-term borrowings |
i 22,251 |
( i 256,286 |
) | |||||
Proceeds from long-term borrowings |
i 500,000 |
i 100,000 |
||||||
Repurchases of common stock |
( i 101 |
) |
( i 137 |
) | ||||
Cash dividends paid |
( i 41,165 |
) |
( i 31,766 |
) | ||||
Proceeds from stock option exercises |
i 6,977 |
i 24,929 |
||||||
Other, net |
( i 1,313 |
) |
( i 2,605 |
) | ||||
Total financing activities |
i 486,649 |
( i 165,865 |
) | |||||
Effect of exchange rate changes on cash and cash equivalents |
( i 12,606 |
) |
i 1,448 |
|||||
Increase in cash and cash equivalents |
i 860,352 |
i 14,090 |
||||||
Cash and cash equivalents: |
||||||||
Beginning of period |
i 393,030 |
i 353,975 |
||||||
End of period |
$ |
i 1,253,382 |
$ | i 368,065 |
||||
1. |
Basis of Presentation |
2. |
Recent Accounting Pronouncements |
3. |
Revenues |
2020 |
2019 |
|||||||
(In thousands) |
||||||||
Contract assets—January 1 |
$ | i 73,039 |
$ | i 58,266 |
||||
Contract assets – March 31 |
i 80,796 |
i 76,323 |
||||||
Change in contract assets – increase |
i 7,757 |
i 18,057 |
||||||
Contract liabilities – January 1 |
i 167,306 |
i 146,162 |
||||||
Contract liabilities – March 31 |
i 194,433 |
i 147,776 |
||||||
Change in contract liabilities – increase |
( i 27,127 |
) |
( i 1,614 |
) | ||||
Net change |
$ |
( i 19,370 |
) |
$ | i 16,443 |
|||
Three months ended March 31, 2020 |
||||||||||||
EIG |
EMG |
Total |
||||||||||
(In thousands) |
||||||||||||
United States |
$ |
i 406,545 |
$ |
i 234,689 |
$ |
i 641,234 |
||||||
International (1) : |
||||||||||||
United Kingdom |
i 14,793 |
i 33,138 |
i 47,931 |
|||||||||
European Union countries |
i 105,676 |
i 88,766 |
i 194,442 |
|||||||||
Asia |
i 164,745 |
i 43,830 |
i 208,575 |
|||||||||
Other foreign countries |
i 82,466 |
i 27,570 |
i 110,036 |
|||||||||
Total international |
i 367,680 |
i 193,304 |
i 560,984 |
|||||||||
Consolidated net sales |
$ |
i 774,225 |
$ |
i 427,993 |
$ |
i 1,202,218 |
||||||
(1) | Includes U.S. export sales of $ i 305.2 million. |
Three months ended March 31, 2019 |
||||||||||||
EIG |
EMG |
Total |
||||||||||
(In thousands) |
||||||||||||
United States |
$ | i 403,392 |
$ | i 260,754 |
$ | i 664,146 |
||||||
International (1) : |
||||||||||||
United Kingdom |
i 15,427 |
i 33,888 |
i 49,315 |
|||||||||
European Union countries |
i 102,785 |
i 106,419 |
i 209,204 |
|||||||||
Asia |
i 193,847 |
i 47,111 |
i 240,958 |
|||||||||
Other foreign countries |
i 91,460 |
i 32,608 |
i 124,068 |
|||||||||
Total international |
i 403,519 |
i 220,026 |
i 623,545 |
|||||||||
Consolidated net sales |
$ | i 806,911 |
$ | i 480,780 |
$ | i 1,287,691 |
||||||
(1) | Includes U.S. export sales of $ i 325.4 million. |
Three months ended March 31, 2020 |
||||||||||||
EIG |
EMG |
Total |
||||||||||
(In thousands) |
||||||||||||
Process and analytical instrumentation |
$ |
i 548,440 |
$ |
— |
$ |
i 548,440 |
||||||
Aerospace and power |
i 225,785 |
i 127,251 |
i 353,036 |
|||||||||
Automation and engineered solutions |
— |
i 300,742 |
i 300,742 |
|||||||||
Consolidated net sales |
$ |
i 774,225 |
$ |
i 427,993 |
$ |
i 1,202,218 |
||||||
Three months ended March 31, 2019 |
||||||||||||
EIG |
EMG |
Total |
||||||||||
(In thousands) |
||||||||||||
Process and analytical instrumentation |
$ | i 577,340 |
$ | — |
$ | i 577,340 |
||||||
Aerospace and power |
i 229,571 |
i 118,878 |
i 348,449 |
|||||||||
Automation and engineered solutions |
— |
i 361,902 |
i 361,902 |
|||||||||
Consolidated net sales |
$ | i 806,911 |
$ | i 480,780 |
$ | i 1,287,691 |
||||||
Three months ended March 31, 2020 |
||||||||||||
EIG |
EMG |
Total |
||||||||||
(In thousands) |
||||||||||||
Products transferred at a point in time |
$ |
i 633,540 |
$ |
i 379,059 |
$ |
i 1,012,599 |
||||||
Products and services transferred over time |
i 140,685 |
i 48,934 |
i 189,619 |
|||||||||
Consolidated net sales |
$ |
i 774,225 |
$ |
i 427,993 |
$ |
i 1,202,218 |
||||||
Three months ended March 31, 2019 |
||||||||||||
EIG |
EMG |
Total |
||||||||||
(In thousands) |
||||||||||||
Products transferred at a point in time |
$ | i 677,833 |
$ | i 435,605 |
$ | i 1,113,438 |
||||||
Products and services transferred over time |
i 129,078 |
i 45,175 |
i 174,253 |
|||||||||
Consolidated net sales |
$ | i 806,911 |
$ | i 480,780 |
$ | i 1,287,691 |
||||||
Three Months Ended |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Balance at the beginning of the period |
$ | i 27,611 |
$ | i 23,482 |
||||
Accruals for warranties issued during the period |
i 3,252 |
i 5,003 |
||||||
Settlements made during the period |
( i 4,217 |
) |
( i 4,789 |
) | ||||
Warranty accruals related to acquired businesses and other during the period |
i 288 |
( i 81 |
) | |||||
Balance at the end of the period |
$ |
i 26,934 |
$ | i 23,615 |
||||
4. |
Earnings Per Share |
Three Months Ended |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Weighted average shares: |
||||||||
Basic shares |
i 228,962 |
i 226,861 |
||||||
Equity-based compensation plans |
i 1,910 |
i 1,825 |
||||||
Diluted shares |
i 230,872 |
i 228,686 |
||||||
5. |
Fair Value Measurements |
Fair Value |
Fair Value |
|||||||
(In thousands) |
||||||||
Mutual fund investments |
$ |
i 7,212 |
$ | i 8,390 |
Recorded Amount |
Fair |
Recorded Amount |
Fair Value |
|||||||||||||
(In thousands) |
||||||||||||||||
Long-term debt, net (including current portion) |
$ |
( i 2,845,880 |
) |
$ |
( i 2,831,990 |
) |
$ | ( i 2,382,041 |
) | $ | ( i 2,531,549 |
) |
6. |
Hedging Activities |
7. |
Inventories, net |
March 31, |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Finished goods and parts |
$ |
i 103,227 |
$ | i 99,773 |
||||
Work in process |
i 130,275 |
i 118,240 |
||||||
Raw materials and purchased parts |
i 420,796 |
i 406,554 |
||||||
Total inventories, net |
$ |
i 654,298 |
$ | i 624,567 |
||||
8. |
Leases |
Three Months Ended |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Operating lease cost |
$ |
i 10,705 |
$ | i 8,671 |
||||
Variable lease cost |
i 1,114 |
i 1,631 |
||||||
Total lease cost |
$ |
i 11,819 |
$ | i 10,302 |
||||
March 31, |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Right of use assets, net |
$ |
i 168,543 |
$ | i 179,679 |
||||
Lease liabilities included in Accrued Liabilities and other |
i 42,001 |
i 43,025 |
||||||
Lease liabilities included in Other long-term liabilities |
i 132,360 |
i 142,620 |
||||||
Total lease liabilities |
$ |
i 174,361 |
$ | i 185,645 |
||||
Three Months Ended |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Right-of-use assets obtained in exchange for new operating liabilities |
$ |
i 8,451 |
$ |
i 1,325 |
||||
Weighted-average remaining lease terms—operating leases (years) |
i 5.76 |
i 6.26 |
||||||
Weighted-average discount rate—operating leases |
i 3.70 |
% |
i 3.88 |
% |
Lease Liability Maturity Analysis |
Operating Leases |
|||
(In thousands) |
||||
Remaining 2020 |
$ |
i 36,470 |
||
2021 |
i 42,132 |
|||
2022 |
i 34,354 |
|||
2023 |
i 26,243 |
|||
2024 |
i 17,781 |
|||
Thereafter |
i 37,719 |
|||
Total lease payments |
i 194,699 |
|||
Less: imputed interest |
i 20,338 |
|||
$ |
i 174,361 |
|||
9. |
Acquisition and Divestiture |
Property, plant and equipment |
$ |
i 2.3 |
||
Goodwill |
i 55.0 |
|||
Other intangible assets |
i 58.7 |
|||
Deferred income taxes |
( i 14.2 |
) | ||
Net working capital and other (1) |
i 14.8 |
|||
Total cash paid |
$ |
i 116.6 |
||
(1) | Includes $ i 6.5 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal. |
10. |
Goodwill |
EIG |
EMG |
Total |
||||||||||
(In millions) |
||||||||||||
Balance at December 31, 2019 |
$ | i 2,892.2 |
$ | i 1,155.3 |
$ | i 4,047.5 |
||||||
Goodwill acquired |
i 55.0 |
— |
i 55.0 |
|||||||||
Purchase price allocation adjustments and other |
i 0.6 |
i 1.1 |
i 1.7 |
|||||||||
Foreign currency translation adjustments |
( i 15.7 |
) |
( i 12.9 |
) |
( i 28.6 |
) | ||||||
Balance at March 31, 2020 |
$ |
i 2,932.1 |
$ |
i 1,143.5 |
$ |
i 4,075.6 |
||||||
11. |
Income Taxes |
Balance at December 31, 2019 |
$ | i 109.1 |
||
Additions for tax positions |
i 6.1 |
|||
Reductions for tax positions |
( i 0.6 |
) | ||
Balance at March 31, 2020 |
$ |
i 114.6 |
||
12. |
Share-Based Compensation |
Three Months Ended |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Stock option expense |
$ |
i 3,373 |
$ | i 2,773 |
||||
Restricted stock expense |
i 3,542 |
i 3,717 |
||||||
PRSU expense |
i 933 |
i 631 |
||||||
Total pre-tax expense |
$ |
i 7,848 |
$ | i 7,121 |
||||
Three Months Ended |
Year Ended |
|||||||
Expected volatility |
i 22.2 |
% |
i 19.1 |
% | ||||
Expected term (years) |
i 5.0 |
i 5.0 |
||||||
Risk-free interest rate |
i 0.52 |
% |
i 2.25 |
% | ||||
Expected dividend yield |
i 1.14 |
% |
i 0.66 |
% | ||||
Black-Scholes-Merton fair value per stock option granted |
$ |
i 11.01 |
$ | i 16.85 |
Shares |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Life |
Aggregate Intrinsic Value |
|||||||||||||
(In thousands) |
(Years) |
(In millions) |
||||||||||||||
Outstanding at December 31, 2019 |
i 4,303 |
$ | i 62.50 |
|||||||||||||
Granted |
i 963 |
i 63.37 |
||||||||||||||
Exercised |
( i 129 |
) |
i 49.26 |
|||||||||||||
Forfeited |
( i 56 |
) |
i 72.12 |
|||||||||||||
Outstanding at March 31, 2020 |
i 5,081 |
$ |
i 62.89 |
i 6.0 |
$ |
i 57.6 |
||||||||||
Exercisable at March 31, 2020 |
i 2,112 |
$ |
i 54.58 |
i 3.3 |
$ |
i 37.3 |
||||||||||
Shares |
Weighted Average Grant Date Fair Value |
|||||||
(In thousands) |
||||||||
Nonvested restricted stock outstanding at December 31, 2019 |
i 561 |
$ | i 72.46 |
|||||
Granted |
i 240 |
i 63.60 |
||||||
Vested |
( i 3 |
) |
i 64.05 |
|||||
Forfeited |
( i 15 |
) |
i 71.34 |
|||||
Nonvested restricted stock outstanding at March 31, 2020 |
i 783 |
$ |
i 69.80 |
|||||
13. |
Retirement and Pension Plans |
Three Months Ended |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Defined benefit plans: |
||||||||
Service cost |
$ |
i 1,950 |
$ | i 1,713 |
||||
Interest cost |
i 5,636 |
i 6,762 |
||||||
Expected return on plan assets |
( i 13,650 |
) |
( i 13,126 |
) | ||||
Amortization of net actuarial loss and other |
i 3,976 |
i 3,287 |
||||||
Pension income |
( i 2,088 |
) |
( i 1,364 |
) | ||||
Other plans: |
||||||||
Defined contribution plans |
i 10,025 |
i 9,108 |
||||||
Foreign plans and other |
i 2,041 |
i 1,562 |
||||||
Total other plans |
i 12,066 |
i 10,670 |
||||||
Total net pension expense |
$ |
i 9,978 |
$ | i 9,306 |
||||
14. |
Contingencies |
15. |
Realignment Costs |
First Quarter of 2020 realignment costs |
||||
Balance at December 31, 2019 |
$ |
i — |
||
Pre-tax charges |
i 43.9 |
|||
Utilization |
( i 7.3 |
) | ||
Foreign currency translation and other |
( i 0.1 |
) | ||
Balance at March 31, 2020 |
$ |
i 36.5 |
||
Three Months Ended March 31, |
||||||||
2019 |
||||||||
(In thousands) |
||||||||
Net sales: |
||||||||
Electronic Instruments |
$ |
774,225 |
$ |
806,911 |
||||
Electromechanical |
427,993 |
480,780 |
||||||
Consolidated net sales |
$ |
1,202,218 |
$ |
1,287,691 |
||||
Operating income and income before income taxes: |
||||||||
Segment operating income: |
||||||||
Electronic Instruments |
$ |
171,271 |
$ |
203,084 |
||||
Electromechanical |
76,564 |
98,813 |
||||||
Total segment operating income |
247,835 |
301,897 |
||||||
Corporate administrative expenses |
(15,795 |
) |
(18,638 |
) | ||||
Consolidated operating income |
232,040 |
283,259 |
||||||
Interest expense |
(22,741 |
) |
(22,653 |
) | ||||
Other income (expense), net |
141,776 |
(3,668 |
) | |||||
Consolidated income before income taxes |
$ |
351,075 |
$ |
256,938 |
||||
2020 |
||||||||
Realignment Costs |
Operating Margins |
|||||||
EIG |
$ | 22.8 |
(300 |
) | ||||
EMG |
20.9 |
(490 |
) | |||||
Total reported in segment operating income |
43.7 |
(370 |
) | |||||
Selling, general and administrative expenses |
0.2 |
|||||||
Total reported in the consolidated statement of income |
$ | 43.9 |
(370 |
) | ||||
Item 1A. |
Risk Factors |
Period |
Total Number of Shares Purchased (1) |
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plan |
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan |
||||||||||||
— |
$ | — |
— |
$ | 489,125,278 |
|||||||||||
612 |
101.40 |
612 |
489,063,223 |
|||||||||||||
399 |
97.81 |
399 |
489,024,195 |
|||||||||||||
Total |
1,011 |
99.98 |
1,011 |
|||||||||||||
(1) | Represents shares surrendered to the Company to satisfy tax withholding obligations in connection with employees’ share-based compensation awards. |
Exhibit Number |
Description | |||
3.2* |
||||
31.1* |
||||
31.2* |
||||
32.1* |
||||
32.2* |
||||
101.INS* |
XBRL Instance Document. | |||
101.SCH* |
XBRL Taxonomy Extension Schema Document. | |||
101.CAL* |
XBRL Taxonomy Extension Calculation Linkbase Document. | |||
101.DEF* |
XBRL Taxonomy Extension Definition Linkbase Document. | |||
101.LAB* |
XBRL Taxonomy Extension Label Linkbase Document. | |||
101.PRE* |
XBRL Taxonomy Extension Presentation Linkbase Document. | |||
104 |
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101). |
* | Filed electronically herewith. |
AMETEK, Inc. (Registrant) | ||
By: |
||
Senior Vice President – Comptroller | ||
(Principal Accounting Officer) |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
12/31/22 | ||||
12/15/21 | ||||
12/31/20 | ||||
12/15/20 | ||||
8/24/20 | ||||
Filed on: | 5/5/20 | 8-K | ||
4/24/20 | ||||
For Period end: | 3/31/20 | |||
3/11/20 | ||||
3/1/20 | ||||
2/29/20 | ||||
2/12/20 | 4, 8-K, SC 13G/A | |||
2/1/20 | ||||
1/31/20 | ||||
1/1/20 | ||||
12/31/19 | 10-K, 11-K, 5, SD | |||
3/31/19 | 10-Q | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/22/24 AMETEK, Inc. 10-K 12/31/23 119:13M 2/21/23 AMETEK, Inc. 10-K 12/31/22 112:14M 2/22/22 AMETEK, Inc. 10-K 12/31/21 113:14M 2/18/21 AMETEK, Inc. 10-K 12/31/20 116:14M |